SG Americas Securities’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,951
Closed -$49K – 2295
2023
Q1
$49K Buy
1,951
+758
+64% +$24.4K ﹤0.01% 3073
2022
Q4
$38K Sell
1,193
-183
-13% -$5.77K ﹤0.01% 2882
2022
Q3
$41K Buy
1,376
+126
+10% +$4.35K ﹤0.01% 3022
2022
Q2
$38K Buy
+1,250
New +$115K ﹤0.01% 3296
2022
Q1
– Sell
-874
Closed -$114K – 2955
2021
Q4
$114K Sell
874
-1,061
-55% -$134K ﹤0.01% 3011
2021
Q3
$182K Buy
+1,935
New +$197K ﹤0.01% 3288

Other funds holding LONA

SG Americas Securities's LONA Position: Q2 2023 in Review

SG Americas Securities sold out of LeonaBio Inc (LONA) in Q2 2023, closing a stake of 1,951 shares — an estimated $49K sold.

SG Americas Securities first reported a position in LONA in Q3 2021 and held it in 6 quarters. The position peaked at $182K in Q3 2021. 77 funds tracked by Wall St. Rank hold LONA as of Q2 2023.

  • SG Americas Securities reported no remaining LeonaBio Inc position as of Q2 2023 after selling out during the quarter.
  • SG Americas Securities sold 1,951 LeonaBio Inc shares in Q2 2023, an estimated $49K.
  • SG Americas Securities first reported a position in LeonaBio Inc in Q3 2021 and held it in 6 quarters.
  • SG Americas Securities's LeonaBio Inc position peaked at $182K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2023.

Based on SG Americas Securities's 13F filing for Q2 2023, filed 10 Jul 2023.